Epitarget AS is a privately owned Scandinavian life science company headquartered in Oslo, Norway. The company is dedicated to developing novel cancer therapies. In current chemotherapy the whole body is treated, not only the diseased parts, severely limiting therapy. Epitarget aims to change this by delivering effective cancer drugs exactly where they are needed.